International MOU inked between chemistry and biomedical talents from Hong Kong, Singapore and Europe for late-stage cancer research enhancement. 27 7 月, 2022 Read More »
Invitrocue announces acquisition of Welala to create life science leadership in Thailand and Asean 23 9 月, 2024 Read More >>
Invitrocue’s Onco-PDO test is Singapore’s and world’s first validated and approved Clinical Cancer Drug Screening service for Personalised Oncology 5 3 月, 2024 Read More >>
